Susan B. Hirsch - 17 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/Christine Klaskin, as Attorney-in-Fact
Issuer symbol
AGEN
Transactions as of
17 Jun 2025
Transactions value $
$0
Form type
4
Filing time
20 Jun 2025, 16:10:04 UTC
Previous filing
02 Jan 2025
Next filing
28 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hirsch Susan B Director C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/Christine Klaskin, as Attorney-in-Fact 20 Jun 2025 0001827663

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +15,000 $0.000000 15,000 17 Jun 2025 Common Stock 15,000 $3.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.